As depicted in Figure 1E, 18 targets (SERPINA3, FCN3, LUM, ASPN, IL1RL1, SFRP4, CD163, MYOT, OGN, MXRA5, LYVE1, MYH6, PLA2G2A, CYP4B1, SERPINE1, HBB, NPPA, and EIF1AY) had the potential binding sites of RBPs, which were differentially expressed in heart failure LV myocardium specimens in contrast to nonfailing controls. The gene discussed is CD163; the disease is heart failure.